The International Journal of Tuberculosis and Lung Disease

The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible [Counter Counterpoint]
pp. 795-795(1)
Authors: Rema Mathew; T. Santha

Role of individual drugs in the chemotherapy of tuberculosis
pp. 796-806(11)
Author: D.A. Mitchison

Case management of childhood pneumonia in developing countries: recent relevant research and current initiatives
pp. 807-826(20)
Authors: Z. Rasmussen; A. Pio; P. Enarson

Occupational risk of tuberculosis among health care workers at the Institute for Pulmonary Diseases of Serbia
pp. 827-831(5)
Authors: V. Skodric; B. Savic; M. Jovanovic; I. Pesic; J. Videnovic; V. Zugic; J. Rakovic; M. Stojkovic

Primary and acquired drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme
pp. 832-838(7)
Authors: Z. Zwolska; E. Augustynowicz-Kopec; M. Klatt

Risk of development of tuberculosis in HIV-infected patients
pp. 839-844(6)
Authors: S. Swaminathan; R. Ramachandran; G. Baskaran; C.N. Paramasivan; U. Ramanathan; P. Venkatesan; R. Prabhakar; M. Datta

Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa
pp. 845-852(8)
Authors: N. Winqvist; A. Nauclér; V. Gomes; I. Djamanca; T. Koivula; H. Jensen; F. Dias; G. Biberfeld; G. Källenius; R. Norberg

A one-year prospective study (1994–1995) for a first evaluation of tuberculosis transmission in French prisons
pp. 853-859(7)
Authors: B. Hanau-Berçot; I. Grémy; L. Raskine; J. Bizet; M.C. Gutierrez; S. Boyer-Mariotte; A. Brégeault; P.H. Lagrange; M.J. Sanson Le Pors

The effects of increasing incentives on adherence to tuberculosis directly observed therapy
pp. 860-865(6)
Authors: H. Davidson; N.W. Schluger; P.H. Feldman; D.P. Valentine; E.E. Telzak; F.N. Laufer

Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens
pp. 866-870(5)
Authors: H.P. Chien; M.C. Yu; M.H. Wu; T.P. Lin; K.T. Luh

Comparative study of Amplicor Mycobacterium PCR and conventional methods for the diagnosis of pleuritis caused by mycobacterial infection
pp. 871-876(6)
Authors: S. Mitarai; H. Shishido; A. Kurashima; A. Tamura; H. Nagai

Comparative performance of PCR-based assay versus microscopy and culture for the direct detection of Mycobacterium tuberculosis in clinical respiratory specimens in Lebanon
pp. 877-881(5)
Authors: G.F. Araj; R.S. Talhouk; L.Y. Itani; W. Jaber; G.W. Jamaleddine

Gender differences in relation to sputum submission and smear-positive pulmonary tuberculosis in Malawi [Notes from the Field]
pp. 882-884(3)
Authors: M.J. Boeree; A.D. Harries; P. Godschalk; Q. Demast; B. Upindi; A. Mwale; T.E. Nyirenda; A. Banerjee; F.M.L. Salaniponi

Correspondence
pp. 885-889(5)

More on the question of optimal chemotherapy in the presence of isoniazid resistance
pp. 890-894(5)
Authors: R. Long; M. Scalcini